These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 24220108

  • 1. Glycopeptide antibiotic biosynthesis.
    Yim G, Thaker MN, Koteva K, Wright G.
    J Antibiot (Tokyo); 2014 Jan; 67(1):31-41. PubMed ID: 24220108
    [Abstract] [Full Text] [Related]

  • 2. Glycopeptides: Update on an old successful antibiotic class.
    Pace JL, Yang G.
    Biochem Pharmacol; 2006 Mar 30; 71(7):968-80. PubMed ID: 16412985
    [Abstract] [Full Text] [Related]

  • 3. Forthcoming therapeutic perspectives for infections due to multidrug-resistant Gram-positive pathogens.
    Cornaglia G, Rossolini GM.
    Clin Microbiol Infect; 2009 Mar 30; 15(3):218-23. PubMed ID: 19335369
    [Abstract] [Full Text] [Related]

  • 4. Oritavancin: a new avenue for resistant Gram-positive bacteria.
    Mercier RC, Hrebickova L.
    Expert Rev Anti Infect Ther; 2005 Jun 30; 3(3):325-32. PubMed ID: 15954849
    [Abstract] [Full Text] [Related]

  • 5. Lipid II and other bactoprenol-bound cell wall precursors as drug targets.
    Schneider T, Sahl HG.
    Curr Opin Investig Drugs; 2010 Feb 30; 11(2):157-64. PubMed ID: 20112165
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and study of antibacterial activities of antibacterial glycopeptide antibiotics conjugated with benzoxaboroles.
    Printsevskaya SS, Reznikova MI, Korolev AM, Lapa GB, Olsufyeva EN, Preobrazhenskaya MN, Plattner JJ, Zhang YK.
    Future Med Chem; 2013 Apr 30; 5(6):641-52. PubMed ID: 23617428
    [Abstract] [Full Text] [Related]

  • 7. Vancomycin resistance: are there better glycopeptides coming?
    Linden PK.
    Expert Rev Anti Infect Ther; 2008 Dec 30; 6(6):917-28. PubMed ID: 19053904
    [Abstract] [Full Text] [Related]

  • 8. Glycopeptide antibiotics: back to the future.
    Butler MS, Hansford KA, Blaskovich MA, Halai R, Cooper MA.
    J Antibiot (Tokyo); 2014 Sep 30; 67(9):631-44. PubMed ID: 25118105
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Genetics of glycopeptide resistance in gram-positive pathogens.
    Courvalin P.
    Int J Med Microbiol; 2005 Mar 30; 294(8):479-86. PubMed ID: 15790292
    [Abstract] [Full Text] [Related]

  • 12. Antibiotics for gram-positive bacterial infections: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, dalbavancin, and telavancin.
    Nailor MD, Sobel JD.
    Infect Dis Clin North Am; 2009 Dec 30; 23(4):965-82, ix. PubMed ID: 19909893
    [Abstract] [Full Text] [Related]

  • 13. Resistance to glycopeptide antibiotics in the teicoplanin producer is mediated by van gene homologue expression directing the synthesis of a modified cell wall peptidoglycan.
    Beltrametti F, Consolandi A, Carrano L, Bagatin F, Rossi R, Leoni L, Zennaro E, Selva E, Marinelli F.
    Antimicrob Agents Chemother; 2007 Apr 30; 51(4):1135-41. PubMed ID: 17220405
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Limitations of presently available glycopeptides in the treatment of Gram-positive infection.
    Ziglam HM, Finch RG.
    Clin Microbiol Infect; 2001 Apr 30; 7 Suppl 4():53-65. PubMed ID: 11688535
    [Abstract] [Full Text] [Related]

  • 16. Telavancin: a lipoglycopeptide antimicrobial for the treatment of complicated skin and skin structure infections caused by gram-positive bacteria in adults.
    Chang MH, Kish TD, Fung HB.
    Clin Ther; 2010 Dec 30; 32(13):2160-85. PubMed ID: 21316534
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Harnessing the synthetic capabilities of glycopeptide antibiotic tailoring enzymes: characterization of the UK-68,597 biosynthetic cluster.
    Yim G, Kalan L, Koteva K, Thaker MN, Waglechner N, Tang I, Wright GD.
    Chembiochem; 2014 Nov 24; 15(17):2613-23. PubMed ID: 25255985
    [Abstract] [Full Text] [Related]

  • 19. β-Lactam and glycopeptide antibiotics: first and last line of defense?
    Jovetic S, Zhu Y, Marcone GL, Marinelli F, Tramper J.
    Trends Biotechnol; 2010 Dec 24; 28(12):596-604. PubMed ID: 20970210
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.